論文

ページタイトル画像

2020年-2023年

  • 2023年
  • 2022年
  • 2021年
  • 2020年

2023年

  1. Iwanaga T, Chiba T, Nakamura M, Kaneko T, Ao J, Qiang N, Ma Y, Zhang J, Kogure T, Yumita S, Ishino T, Ogawa K, Kan M, Nakagawa M, Fujiwara K, Fujita N, Sakuma T, Kanzaki H, Koroki K, Kusakabe Y, Inoue M, Kobayashi K, Kanogawa N, Kiyono S, Kondo T, Nakagawa R, Ogasawara S, Nakamoto S, Muroyama R, Kato J, Kanda T, Maruyama H, Mimura N, Honda T, Murayama T, Nakamura H, Kato N. Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells. Biochem Biophys Res Commun. 2023 Jan 29;642:192-200.

  2. Nagashima H, Mikata R, Isono S, Ogasawara S, Sugiyama H, Ohno I, Yasui S, Matsumura T, Koroki K, Kusakabe Y, Miura Y, Kan M, Maruta S, Yamada T, Takemura R, Sato Y, Kato J, Kato N. Phase II study comparing nasal pressure monitoring with capnography during invasive endoscopic procedures: a single-center, single-arm trial. Sci Rep. 2023 Jan 23;13(1):1265.

  3. Nakagawa M, Inoue M, Ogasawara S, Maruta S, Okubo T, Itokawa N, Iino Y, Obu M, Haga Y, Seki A, Kikuchi Y, Kogure T, Yumita S, Ishino T, Ogawa K, Fujiwara K, Iwanaga T, Fujita N, Sakuma T, Kojima R, Kanzaki H, Koroki K, Taida T, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Itobayashi E, Atsukawa M, Koma Y, Azemoto R, Ito K, Mizumoto H, Shinozaki M, Kato J, Kato N. Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practice. Cancer. 2023 Feb 15;129(4):590-599.

  4. Kumagai K, Mawatari S, Moriuchi A, Oda K, Takikawa Y, Kato N, Oda S, Inoue K, Terai S, Genda T, Shimizu M, Sakaida I, Mochida S, Ido A. Early-phase prothrombin time-international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement. Hepatol Res. 2023 Feb;53(2):160-171.

  5. Arai J, Otoyama Y, Nozawa H, Kato N, Yoshida H. The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: A review Oncogene. 2023 Feb;42(8):549-558.

  6. Nishio M, Kunisaki R, Shibata W, Ajioka Y, Hirasawa K, Takase A, Chiba S, Inayama Y, Ueda W, Okawa K, Otake H, Ogashiwa T, Kinoshita H, Saigusa Y, Kimura H, Kato J, Maeda S. Serrated polyps in patients with ulcerative colitis: Unique clinicopathological and biological characteristics. PLoS One. 2023 Feb 24;18(2):e0282204.

  7. Ogawa K, Chiba T, Nakamura M, Arai J, Zhang J, Ma Y, Qiang NA, Ao J, Yumita S, Ishino T, Kan M, Iwanaga T, Nakagawa M, Fujiwara K, Sakuma T, Kanzaki H, Koroki K, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Kondo T, Nakagawa R, Ogasawara S, Muroyama R, Nakamoto S, Kanda T, Maruyama H, Kato J, Matsumoto S, Arai T, Motohashi S, Kato N. Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors. Anticancer Res. 2023 Mar;43(3):1043-1052.

  8. Kanogawa N, Ogasawara S, Maruta S, Iino Y, Obu M, Ishino T, Ogawa K, Yumita S, Iwanaga T, Unozawa H, Nakagawa M, Fujiwara K, Sakuma T, Fujita N, Kojima R, Kanzaki H, Koroki K, Kobayashi K, Inoue M, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Itobayashi E, Koma Y, Azemoto R, Kato J, Kato N. Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma. BMC Gastroenterol. 2023 Mar 11;23(1):70.

  9. Yumita S, Ogasawara S, Nakagawa M, Maruta S, Okubo T, Itokawa N, Iino Y, Obu M, Haga Y, Seki A, Kogure T, Ishino T, Ogawa K, Fujiwara K, Iwanaga T, Fujita N, Sakuma T, Kojima R, Kanzaki H, Koroki K, Inoue M, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Itobayashi E, Atsukawa M, Koma Y, Azemoto R, Ito K, Mizumoto H, Kato J, Kato N. Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice. BMC Gastroenterol. 2023 Mar 31;23(1):101.

  10. Kudo M, Finn RS, Cheng AL, Zhu AX, Ducreux M, Galle PR, Sakamoto N, Kato N, Nakano M, Jia J, Vogel A. Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study. Liver Cancer. 2023 Mar 4;12(5):479-493.

  11. Takahashi K, Ohyama H, Takiguchi Y, Sekine Y, Toyama S, Yamada N, Sugihara C, Kan M, Ouchi M, Nagashima H, Iino Y, Kusakabe Y, Okitsu K, Ohno I, Kato N. Secondary Sclerosing Cholangitis After Emphysematous Cholecystitis. ACG Case Rep J. 2023 Mar 23;10(3):e01016.

  12. Fujiwara K, Yasui S, Kondo T, Nakamura M, Arai M, Kanda T, Yokosuka O, Ohtsuka M, Abe R, Kato N. Thirty-two years' experience of treating fulminant hepatitis in a Japanese single center. Hepatol Res. 2023 Apr;53(4):357-369.

  13. Kato N, Kudo M, Tsuchiya K, Hagihara A, Numata K, Aikata H, Inaba Y, Kondo S, Motomura K, Okano N, Ikeda M, Morimoto M, Kuroda S, Kimura A. Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study. Hepatol Res. 2023 Apr;12(7):8490-8498.

  14. Okimoto K, Hirotsu Y, Arai M, Amemiya K, Akizue N, Ohta Y, Taida T, Saito K, Ohyama H, Matsumura T, Nishimura M, Matsushita K, Matsusaka K, Oyama T, Mochizuki H, Chiba T, Kato J, Ikeda J, Yokosuka O, Kato N, Omata M. Validity of pathological diagnosis for early colorectal cancer in genetic background. Cancer Med. 2023 Apr;12(7):8490-8498.

  15. Goto C, Okimoto K, Matsusaka K, Matsumura T, Akizue N, Ohta Y, Taida T, Saito K, Kato J, Kato N. Long-term vonoprazan administration causes gastric fundic gland-type hyperplastic polyps and chronic bleeding. Clin J Gastroenterol. 2023 Apr;16(2):159-163.

  16. Ishino T, Kawashima S, Tanji E, Ueno T, Ueda Y, Ogasawara S, Sato K, Mano H, Ishihara S, Kato N, Kawazu M, Togashi Y. Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens. Br J Cancer. 2023 Apr;128(6):1166-1175.

  17. Dao HV, Hoang LB, Nguyen BP, Nguyen HL, Goldberg R, Allison J, Dao TMA, Matsumura T, Dao LV. Esophageal mucosal admittance: a new technique to diagnose gastroesophageal reflux disease – is it feasible? Clin Exp Gastroenterol. 2023 Apr 7;16:45-54.

  18. Takahashi K, Ohyama H, Takiguchi Y, Kan M, Ouchi M, Nagashima H, Ohno I, Kato N. Feasibility of Biliary Drainage Using a Novel Integrated Biliary Stent and Nasobiliary Drainage Catheter System for Acute Cholangitis. Cureus. 2023 Apr 12;15(4):e37477.

  19. Takahashi K, Ohyama H, Takiguchi Y, Sekine Y, Toyama S, Yamada N, Sugihara C, Kan M, Ouchi M, Nagashima H, Iino Y, Kusakabe Y, Okitsu K, Ohno I, Kato N. Efficacy and Safety of Electrohydraulic Lithotripsy Using Peroral Cholangioscopy under Endoscopic Retrograde Cholangiopancreatography Guidance in Older Adults: A Single-Center Retrospective Study. Medicina (Kaunas). 2023 Apr 19;59(4):795.

  20. Qiang N, Ao J, Nakamura M, Chiba T, Kusakabe Y, Kaneko T, Kurosugi A, Kogure T, Ma Y, Zhang J, Ogawa K, Kan M, Iwanaga T, Sakuma T, Kanayama K, Kanzaki H, Kojima R, Nakagawa R, Kondo T, Nakamoto S, Muroyama R, Kato J, Mimura N, Ma A, Jin J, Kato N. Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinoma. Int Immunopharmacol. 2023 May;118:110068.

  21. Miura Y, Tsuji Y, Yoshio T, Hatta W, Yabuuchi Y, Hoteya S, Kikuchi D, Tsuji S, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Masamune A, Fujishiro M. Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study. Gastrointest Endosc. 2023 May;97(5):889-897.

  22. Saeki I, Yamasaki T, Yamauchi Y, Kawaoka T, Uchikawa S, Hiramatsu A, Aikata H, Kobayashi K, Kondo T, Ogasawara S, Chiba T, Kawano R, Chayama K, Kato N, Takami T. Impact of skeletal muscle volume on patients with BCLC stage-B hepatocellular carcinoma undergoing sorafenib therapy. Cancer Med. 2023 May;12(9):10625-10635.

  23. Arai M, Abe M, Kitahara S, Sakuma N, Ohno I, Takahashi K, Imai C, Saeki H, Suzuki T, Uzawa K, Hanazawa T, Takiguchi Y. Sequential administration of PD‑1 inhibitor and cetuximab causes pneumonia. Oncol Lett. 2023 May 19;26(1):288.

  24. Ohyama H, Hirotsu Y, Amemiya K, Miura Y, Hirose S, Oyama T, Iimuro Y, Kojima Y, Mikata R, Mochizuki H, Kato N, Omata M. Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile. Cancer. 2023 Jun 1;129(11):1714-1722.

  25. Takahashi K, Ohyama H, Takiguchi Y, Kan M, Ouchi M, Nagashima H, Ohno I, Kato N. Endoscopic Transpapillary Stenting for Malignant Hilar Biliary Stricture: Side-by-Side Placement versus Partial Stent-in-Stent Placement. J Pers Med. 2023 May 14;13(5):831.

  26. Kojima R, Nakamoto S, Kogure T, Ma Y, Ogawa K, Iwanaga T, Qiang N, Ao J, Nakagawa R, Muroyama R, Nakamura M, Chiba T, Kato J, Kato N. Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma. World J Virol. 2023 Jun 25;12(3):209-220.

  27. Shiratori W, Matsumura T, Okimoto K, Akizue N, Matsusaka K, Ohyama Y, Mamiya Y, Nakazawa H, Takahashi S, Horio R, Goto C, Sonoda M, Kurosugi A, Nagashima A, Ishikawa T, Kaneko T, Kanayama K, Ohta Y, Saito K, Taida T, Shiko Y, Ozawa Y, Kato J, Ikeda J, Kato N. Long-Term Course of Gastric Submucosal Tumors: Growth Speed and Size-Increasing Factors. Gastrointest Endosc. 2023 Jun;97(6):1052-1058.e2.

  28. Inoki K, Takamaru H, Furuhashi H, Kishida Y, Shimodate Y, Sumida Y, Hosotani K, Ueyama H, Furumoto Y, Hashimoto S, Takeuchi Y, Ichijima R, Yoshizawa Y, Suzuki T, Minoda Y, Mizukami K, Matsumura T, Kasai T, Yamamura T, Ohnita K, Hara K, Esaki M, Katagiri A, Ishikawa H, Gotoda T. Management of colorectal high-grade dysplasia or cancer resected by cold snare polypectomy: a multicenter exploratory study. J Gastroenterol. 2023 Jun;58(6):554-564.

  29. Hashimoto R, Matsusaka K, Matsumura T, Hayano K, Kato N, Matsubara H, Ikeda JI. The neuroendocrine carcinoma component of gastric mixed adenoneuroendocrine carcinoma could develop with MLH1 deficiency independent of TP53 mutation. Pathol Int. 2023 Jun;73(6):261-263.

  30. Minami T, Sato M, Toyoda H, Yasuda S, Yamada T, Nakatsuka T, Enooku K, Nakagawa H, Fujinaga H, Izumiya M, Tanaka Y, Otsuka M, Ohki T, Arai M, Asaoka Y, Tanaka A, Yasuda K, Miura H, Ogata I, Kamoshida T, Inoue K, Nakagomi R, Akamatsu M, Mitsui H, Fujie H, Ogura K, Uchino K, Yoshida H, Hanajiri K, Wada T, Kurai K, Maekawa H, Kondo Y, Obi S, Teratani T, Masaki N, Nagashima K, Ishikawa T, Kato N, Yotsuyanagi H, Moriya K, Kumada T, Fujishiro M, Koike K, Tateishi R. Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals. J Hepatol. 2023 Jun 24:S0168-8278(23)00424-5.

  31. Kondo T, Fujiwara K, Nakagawa M, Fujimoto K, Yumita S, Ishino T, Ogawa K, Iwanaga T, Koroki K, Kanzaki H, Inoue M, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Ogasawara S, Nakamoto S, Chiba T, Kato J, Kato N. Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients. Sci Rep. 2023 Jul 17;13(1):11524.

  32. Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, Katayama H, Takada R, Kobayashi S, Ikeda M, Miwa H, Okano N, Kuramochi H, Sekimoto M, Okusaka T, Ozaka M, Todaka A, Gotoh K, Tobimatsu K, Yamaguchi H, Nakagohri T, Kajiura S, Sudo K, Okamura K, Shimizu S, Shirakawa H, Kato N, Sano K, Iwai T, Fujimori N, Ueno M, Ishii H, Furuse J; Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG). Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106. Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713.

  33. Kamezaki H, Yoshikawa H, Iwanaga T, Tokunaga M, Maeda T, Senoo J, Ohyama H, Kato N. Endoscopic papillary large balloon dilatation-assisted retrieval of a proximally migrated double pigtail stent from the bile duct: A case report DEN Open. 2023 Jul 10;4(1):e272.

  34. Kan M, Chiba T, Konno R, Kouchi Y, Mishima T, Kawashima Y, Kishimoto T, Ohtsuka M, Ohara O, Kato N. Bile proteome analysis by high-precision mass spectrometry to examine novel biomarkers of primary sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2023 Jul;30(7):914-923.

  35. Kondo T, Fujimoto K, Fujiwara K, Yumita S, Ishino T, Ogawa K, Nakagawa M, Iwanaga T, Koroki K, Kanzaki H, Inoue M, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Ogasawara S, Nakamoto S, Chiba T, Kato J, Fujiwara K, Kato N. Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury. Sci Rep. 2023 Aug 28;13(1):14043.

  36. Ohta Y, Taida T, Kato J, Ogasawara S, Oyama Y, Mamiya Y, Nakazawa H, Horio R, Goto C, Takahashi S, Kurosugi A, Sonoda M, Shiratori W, Kaneko T, Yokoyama Y, Akizue N, Ishigami H, Koseki H, Okimoto K, Saito K, Saito M, Matsumura T, Nakagawa T, Masuya Y, Fukuda Y, Kitsukawa Y, Shimura H, Tsuyuguchi T, Kato N. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000. Digestion. 2023;104(4):328-334.

  37. Taida T, Ohta Y, Kato J, Ogasawara S, Ohyama Y, Mamiya Y, Nakazawa H, Horio R, Goto C, Takahashi S, Kurosugi A, Sonoda M, Shiratori W, Kaneko T, Yokoyama Y, Akizue N, Iino Y, Kumagai J, Ishigami H, Koseki H, Okimoto K, Saito K, Saito M, Matsumura T, Nakagawa T, Okabe S, Saito H, Kato K, Uehara H, Mizumoto H, Koma Y, Azemoto R, Ito K, Kamezaki H, Mandai Y, Masuya Y, Fukuda Y, Kitsukawa Y, Shimura H, Tsuyuguchi T, Kato N. Treatment strategy changes for inflammatory bowel diseases in biologic era: results from a multicenter cohort in Japan, Far East 1000. Sci Rep. 2023 Aug 21;13(1):13555.

  38. Tsuchiya S, Koizumi J, Kondo T, Fujiwara K, Kato N, Fujimoto H, Uno T. TIPS Reduction by Parallel Placement of Amplatzer Vascular Plug and Stent. Cardiovasc Intervent Radiol. 2023 Aug;46(8):1107-1110.

  39. Ono R, Goto H, Oyama Y, Tateishi K, Takaoka H, Kato N, Kobayashi Y. Hepatic encephalopathy due to cardiac cirrhosis. Clin Case Rep. 2023 Aug 25;11(9):e7843.

  40. Fujiwara K, Kondo T, Fujimoto K, Koizumi J, Kato N. Percutaneous Transhepatic Direct Portosystemic Shunt for a Patient With Budd-Chiari Syndrome Using a Balloon as a Target in a Stenotic Inferior Vena Cava. Cureus. 2023 Sep 9;15(9):e44967.

  41. Matsumura T, Ebigbo A, Römmele C, Ikematsu H, Ishigami H, Suzuki T, Harada H, Yada T, Takatori Y, Takeuchi M, Okimoto K, Akizue N, Maruoka D, Kitagawa Y, Minamide T, Iwaki T, Amano Y, Matsusaka K, Nagashima K, Maehata T, Yahagi N, Messmann H, Kato N. Diagnostic value of adding magnifying chromoendoscopy to magnifying narrow-band imaging endoscopy for colorectal polyps. Clin Gastroenterol Hepatol. 2023 Sep;21(10):2551-2559.e2.

  42. Akizue N, Okimoto K, Hirotsu Y, Amemiya K, Kaneko T, Ohta Y, Taida T, Saito K, Matsumura T, Nishimura M, Matsushita K, Mochizuki H, Chiba T, Arai M, Kato J, Omata M, Kato N. Carcinogenic potential in regenerated mucosa after endoscopic resection of esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 2023 Sep;38(9):1546-1551. doi: 10.1111/jgh.16219.

  43. Fujiwara K, Yasui S, Kondo T, Yokosuka O, Kato N. Letter to the Editor: Long-term experience in treating autoimmune hepatitis with acute presentation. Liver Transpl. 2023 Sep 1;29(9):E31-E32.

  44. Okimoto K, Matsumura T, Matsusaka K, Inaba Y, Ishikawa T, Akizue N, Kaneko T, Ota M, Ohta Y, Taida T, Saito K, Ogasawara S, Maruoka D, Kato J, Ikeda JI, Kato N. Outcomes for Underwater Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection of 21-30-mm Colorectal Polyps: A Feasible Study. Dig Dis Sci. 2023 Oct;68(10):3963-3973.

  45. Nagashima A, Okimoto K, Nakagawa R, Akizue N, Matsumura T, Oura H, Kojima R, Goto C, Takahashi S, Horio R, Kurosugi A, Ishikawa T, Shiratori W, Kaneko T, Kanayama K, Ohta Y, Taida T, Saito K, Chiba T, Kato J, Kato N. Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA-mRNA integral profiling. Sci Rep. 2023 Nov 11;13(1):19661.

  46. Takahashi K, Ohyama H, Takiguchi Y, Sekine Y, Toyama S, Yamada N, Sugihara C, Kan M, Ouchi M, Nagashima H, Iino Y, Kusakabe Y, Okitsu K, Ohno I, Kato N. Safety of endoscopic ultrasound-guided fine-needle aspiration for pancreatic solid mass in the elderly: A single-center retrospective study. Geriatr Gerontol Int. 2023 Nov;23(11):836-841.

  47. Kanzaki H, Ogasawara S, Okubo T, Itokawa N, Yoshino R, Fujimoto K, Kogure T, Yumita S, Ishino T, Ogawa K, Iwanaga T, Nakagawa M, Fujiwara K, Kojima R, Koroki K, Inoue M, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Itobayashi E, Atsukawa M, Kato J, Kato N. Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis. Drugs Real World Outcomes. 2023 Dec;10(4):513-520.

  48. Kobayashi K, Ogasawara S, Maruta S, Okubo T, Itokawa N, Haga Y, Seko Y, Moriguchi M, Watanabe S, Shiko Y, Takatsuka H, Kanzaki H, Koroki K, Inoue M, Nakamura M, Kiyono S, Kanogawa N, Kondo T, Suzuki E, Ooka Y, Nakamoto S, Inaba Y, Ikeda M, Okabe S, Morimoto N, Itoh Y, Nakamura K, Ito K, Azemoto R, Atsukawa M, Itobayashi E, Kato N. A prospective study exploring the safety and efficacy of lenvatinib for patients with advanced hepatocellular carcinoma and high tumor burden: The LAUNCH study. Clin Cancer Res. 2023 Dec;55(12):1072-1080.

  49. Fujiwara K, Kondo T, Fujimoto K, Fujie M, Kanogawa N, Ogasawara S, Kato N. Use of disposable endoscope for variceal sclerotherapy. Endoscopy. 2023 Dec;55(S 01):E1248-E1249.

  50. Goto C, Okimoto K, Matsumura T, Akizue N, Matsusaka K, Kato J, Kato N. Gel immersion endoscopic mucosal resection for pedunculated Brunner's gland hyperplasia in the duodenal bulb near the pylorus. Endoscopy. 2023 Dec;55(S 01):E985-E986.

  51. Okimoto K, Matsumura T, Fujie M, Akizue N, Matsusaka K, Kato J, Kato N. Endoscopic submucosal dissection for early gastric cancer, using a disposable endoscope. Endoscopy. 2023 Dec;55(S 01):E881-E882.

  52. Antonelli G, Bevivino G, Pecere S, Ebigbo A, Cereatti F, Akizue N, Di Fonzo M, Coppola M, Barbaro F, Sharma P, Walter BM, Caruso A, Okimoto K, Antenucci C, Matsumura T, Zerboni G, Grossi C, Meinikheim M, Papparella LG, Correale L, Costamagna G, Repici A, Spada C, Messmann H, Hassan C, Iacopini F. Texture and Colour Enhancing Imaging versus High-Definition White Light Endoscopy for Detection of Colorectal Neoplasia: a Randomised Trial. Endoscopy. 2023 Dec;55(12):1072-1080.

  53. Ohyama H, Hirotsu Y, Amemiya K, Mikata R, Amano H, Hirose S, Oyama T, Iimuro Y, Kojima Y, Mochizuki H, Kato N, Omata M. Development of a molecular barcode detection system for pancreaticobiliary malignancies and comparison with next-generation sequencing. Cancer Genet. 2023 Dec 14;280-281:6-12.

  54. Takahashi K, Ohyama H, Ohno I, Takiguchi Y, Kato N. A Case of Primary Sclerosing Cholangitis Complicated With Liver Abscess Caused by Hyperviscous Klebsiella pneumoniae. Cureus. 2023 Dec 29;15(12):e51277.

  55. Ohyama H, Hirotsu Y, Mochizuki H, Kato N, Omata M. Distinct Genomic Profiles of Two Small Malignant Lesions Associated With an Intraductal Papillary Mucinous Neoplasm Co-occurring in a Patient. Cureus. 2023 Dec 31;15(12):e51394.

  56. Kakisaka K, Nakayama N, Kumagai K, Hisanaga T, Kondo T, Setsu T, Sato S, Kooka Y, Endo K, Yoshida Y, Oikawa T, Kuroda H, Miyasaka A, Abe R, Nakada T, Ikura Y, Harada K, Genda T, Terai S, Kato N, Takami T, Ido A, Mochida S, Matsumoto T, Tanaka A. Distinction of Drug-Induced Liver Injury From Autoimmune Hepatitis in Patients With Acute Liver Injury: Proposal of a Combination of Diagnostic Scores. Gastro Hep Advances. 2023;2:497–504.

2022年

  1. Kondo T, Koroki K, Maruta S, Kanzaki H, Kanayama K, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Ogasawara S, Suzuki E, Ooka Y, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Kato N. Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma. PloS One. 2022 Jan 27;17(1):e0261619.

  2. Suzuki K, Kakuta Y, Naito T, Takagawa T, Hanai H, Araki H, Sasaki Y, Sakuraba H, Sasaki M, Hisamatsu T, Motoya S, Matsumoto T, Onodera M, Ishiguro Y, Nakase H, Andoh A, Hiraoka S, Shinozaki M, Fujii T, Katsurada T, Kobayashi T, Fujiya M, Otsuka T, Oshima N, Suzuki Y, Sato Y, Hokari R, Noguchi M, Ohta Y, Matsuura M, Kawai Y, Tokunaga K, Nagasaki M, Kudo H, Minegishi N, Okamoto D, Shimoyama Y, Moroi R, Kuroha M, Shiga H, Li D, McGovern DPB, Kinouchi Y, Masamune A; MENDEL study group. Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 Jan 5;28(1):21-31.

  3. Suzuki T, Seki Y, Matsumura T, Arai M, Hanazawa T, Okamoto Y, Suzuki H, Kasama K, Umezawa A, Kurokawa Y, Hoppo T. Reflux-related Extraesophageal Symptoms Until Proven Otherwise: A Direct Measurement of Abnormal Proximal Exposure Based on Hypopharyngeal Multichannel Intraluminal Impedance as a Reliable Indicator for Successful Treatment Outcomes. J Neurogastroenterol Motil. 2022 Jan 30;28(1):69-77.

  4. Okimoto K, Maruoka D, Matsumura T, Kanayama K, Akizue N, Ohta Y, Taida T, Saito K, Inaba Y, Kawasaki Y, Arai M, Kato J, Kato N. Utility of underwater EMR for nonpolypoid superficial nonampullary duodenal epithelial tumors ≤20 mm. Gastrointest Endosc. 2022 Jan;95(1):140-148.

  5. Okimoto K, Maruoka D, Matsumura T, Shiratori W, Nagashima A, Ishikawa T, Tokunaga M, Kaneko T, Oura H, Kanayama K, Akizue N, Ohta Y, Taida T, Saito K, Arai M, Kato J, Kato N. Long-term outcomes of cold snare polypectomy for superficial non-ampullary duodenal epithelial tumors. J Gastroenterol Hepatol. 2022 Jan;37(1):75-80.

  6. Fan M, Arai M, Tawada A, Chiba T, Fukushima R, Uzawa K, Shiiba M, Kato N, Tanzawa H, Takiguchi Y, Takiguchi Y. Contrasting functions of the epithelial‑stromal interaction 1 gene, in human oral and lung squamous cell cancers. Oncol Rep. 2022 Jan;47(1):5.

  7. Yabuuchi Y, Hatta W, Tsuji Y, Yoshio T, Kakushima N, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Fujishiro M, Masamune A, Ono H. Influence of hospital volume on bleeding after endoscopic submucosal dissection for early gastric cancer in Japan: a multicenter propensity score-matched analysis. Surg Endosc. 2022 Jun;36(6):4004-4013.

  8. Seko Y, Moriguchi M, Takahashi A, Yamaguchi K, Umemura A, Okuda K, Kataoka S, Unozawa H, Kobayashi K, Ogasawara S, Sato R, Tsuchiya S, Watanabe S, Morimoto N, Iwai K, Aramaki T, Kato N, Itoh Y. Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents. J Gastroenterol. 2022 Feb;57(2):90-98.

  9. Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Kurosaki M, Ido A, Miki D, Yoshiji H, Takikawa Y, Sakamori R, Hiasa Y, Nakao K, Kato N, Ueno Y, Yatsuhashi H, Itoh Y, Tateishi R, Suda G, Takami T, Nakamoto Y, Asahina Y, Matsuura K, Yamashita T, Kanto T, Akuta N, Terai S, Shimizu M, Sobue S, Miyaki T, Moriuchi A, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T. Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis. J Gastroenterol. 2022 Feb;57(2):120-132.

  10. Miyauchi E, Taida T, Kawasumi M, Ohkusa T, Sato N, Ohno H. Analysis of colonic mucosa-associated microbiota using endoscopically collected lavage. Sci Rep. 2022 Feb 2;12(1):1758.

  11. Yamasaki T, Saeki I, Yamauchi Y, Matsumoto T, Suehiro Y, Kawaoka T, Uchikawa S, Hiramatsu A, Aikata H, Kobayashi K, Kondo T, Ogasawara S, Chiba T, Takami T, Chayama K, Kato N, Sakaida I. Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment. Liver Cancer. 2022 Feb 22;11(4):329-340.

  12. Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, Izumi N, Yamasaki T, Nojiri S, Hino K, Tsumura H, Kuzuya T, Isoda N, Moriguchi M, Aino H, Ido A, Kawabe N, Nakao K, Wada Y, Ogasawara S, Yoshimura K, Okusaka T, Furuse J, Kokudo N, Okita K, Johnson PJ, Arai Y. Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma. Liver Cancer. 2022 Feb 10;11(4):354-367.

  13. Oura H, Matsumura T, Fujie M, Ishikawa T, Nagashima A, Shiratori W, Tokunaga M, Kaneko T, Imai Y, Oike T, Yokoyam Y, Akizue N, Ohta Y, Okimoto K, Arai M, Nakagawa Y, Inada M, Yamagushi K, Kato J, Kato N. Development and evaluation of a double-check support system using artificial intelligence in endoscopic screening for gastric cancer. Gastric Cancer. 2022 Mar;25(2):392-400.

  14. Hayashi Y, Hatta W, Tsuji Y, Yoshio T, Yabuuchi Y, Hoteya S, Tsuji S, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Miyake A, Fujishiro M, Masamune A, Takehara T. The degree of mucosal atrophy is associated with post-endoscopic submucosal dissection bleeding in early gastric cancer. J Gastroenterol Hepatol. 2022 May;37(5):870-877.

  15. Ogasawara S, Koroki K, Makishima H, Wakatsuki M, Takahashi A, Yumita S, Nakagawa M, Ishino T, Ogawa K, Fujiwara K, Iwanaga T, Sakuma T, Fujita N, Kojima R, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Ozawa Y, Kawasaki Y, Kurokawa T, Hanaoka H, Tsuji H, Kato N. Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial. BMJ Open. 2022 Apr 8;12(4):e059779.

  16. Llovet JM, Vogel A, Madoff DC, Finn RS, Ogasawara S, Ren Z, Mody K, Li JJ, Siegel AB, Dubrovsky L, Kudo M. Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment. Cardiovasc Intervent Radiol. 2022 Apr;45(4):405-412.

  17. Ogawa K, Kanzaki H, Chiba T, Ao J, Qiang N, Ma Y, Zhang J, Yumita S, Ishino T, Unozawa H, Kan M, Iwanaga T, Nakagawa M, Fujiwara K, Fujita N, Sakuma T, Koroki K, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Ogasawara S, Suzuki E, Muroyama R, Nakamoto S, Kanda T, Maruyama H, Mimura N, Kato J, Motohashi S, Kato N. Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience. J Cancer. 2022 May 16;13(8):2656-2661.

  18. Okimoto K, Maruoka D, Matsumura T, Kanayama K, Akizue N, Ohta Y, Taida T, Saito K, Inaba Y, Kawasaki Y, Kato J, Kato N. Appropriate selection of endoscopic resection for superficial nonampullary duodenal adenomas in association with recurrence. Gastrointest Endosc. 2022 May;95(5):939-947.

  19. Kudo M, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer DH, Verslype C, Zagonel V, Fartoux L, Vogel A, Sarker D, Verset G, Chan SL, Knox J, Daniele B, Yau T, Gurary EB, Siegel AB, Wang A, Cheng AL, Zhu AX; KEYNOTE-224 Investigators. Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib. Eur J Cancer. 2022 May;167:1-12.

  20. Mochida S, Nakayama N, Terai S, Yoshiji H, Shimizu M, Ido A, Inoue K, Genda T, Takikawa Y, Takami T, Kato N, Abe M, Abe R, Inui A, Ohira H, Kasahara M, Chayama K, Hasegawa K, Tanaka A. Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan. Hepatol Res. 2022 May;52(5):417-421.

  21. Fujiwara K, Yasui S, Kondo T, Kato N. Corticosteroid use in indeterminate acute liver failure. Liver Int. 2022 May;42(5):1209.

  22. Shima Y, Sugiyama H, Ogasawara S, Kan M, Maruta S, Yamada T, Miura Y, Asano K, Sensui M, Nagashima H, Yokoyama M, Kusakabe Y, Yasui S, Ohno I, Mikata R, Tsuyuguchi T, Horikoshi T, Mishima T, Kuboki S, Takayashiki T, Ohtsuka M, Kato J, Kato N. Diagnostic value of peroral cholangioscopy in addition to computed tomography for indeterminate biliary strictures. Surg Endosc. 2022 May;36(5):3408-3417.

  23. Sensui M, Yasui S, Ogasawara S, Kamezaki H, Kan M, Maruta S, Yamada T, Miura Y, Asano K, Shima Y, Nagashima H, Yokoyama M, Kusakabe Y, Sugiyama H, Ohno I, Mikata R, Kato J, Tsuyuguchi T, Kato N. Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis. Ann Hepatol. May-Jun 2022;27(3):100696.

  24. Takahashi K, Ohyama H, Ouchi M, Kan M, Nagashima H, Iino Y, Kusakabe Y, Okitsu K, Ohno I, Takiguchi Y, Kato N. Feasibility of a Single Pigtail Stent Made by Cutting a Nasobiliary Drainage Tube in Endoscopic Transpapillary Gallbladder Stenting for Acute Cholecystitis. Cureus. 2022 May 17;14(5):e25072.

  25. Kanayama K, Kato J, Shiratori W, Nagashima A, Ohta Y, Taida T, Saito K, Goto C, Takahashi S, Horio R, Kurosugi A, Ishikawa T, Kaneko T, Akizue N, Okimoto K, Matsumura T, Kato N. Anti-TNFα antibody versus non-anti-TNFα molecular agents for ulcerative colitis patients who failed initial anti-TNFα therapy. J Gastroenterol Hepatol. 2022 Jun;37(6):1083-1089.

  26. Okimoto K, Matsumura T, Maruoka D, Kurosugi A, Nagashima A, Ishikawa T, Kaneko T, Kanayama K, Akizue N, Ohta Y, Taida T, Saito K, Kato J, Kato N. Magnified endoscopy with texture and color enhanced imaging with indigo carmine for superficial nonampullary duodenal tumor: A pilot study. Sci Rep. 2022 Jun 20;12(1):10381.

  27. Suzuki K, Igata H, Abe M, Yamamoto Y; small RNA based cancer classification project. Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities. Cancer Sci. 2022 Jun;113(6):2144-2166.

  28. Verset G, Borbath I, Karwal M, Verslype C, Van Vlierberghe H, Kardosh A, Zagonel V, Stal P, Sarker D, Palmer DH, Vogel A, Edeline J, Cattan S, Kudo M, Cheng AL, Ogasawara S, Daniele B, Chan SL, Knox JJ, Qin SK, Siegel AB, Chisamore M, Hatogai K, Wang A, Finn RS, Zhu AX. Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial. Clin Cancer Res. 2022 Jun 13;28(12):2547-2554.

  29. Muroyama R, Nakagawa R, Matubara Y, Hirata Y, Omata M, Shirasawa H, Kato N. Fusion HBx from HBV integrant affects hepatocarcinogenesis through deregulation of ER stress response. Virus Res. 2022 Jul 2;315:198787.

  30. Nagami Y, Hatta W, Tsuji Y, Yoshio T, Kakushima N, Hoteya S, Tsuji S, Fukunaga S, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Yoshida H, Fujishiro M, Masamune A, Fujiwara Y. Antithrombotics increase bleeding after endoscopic submucosal dissection for gastric cancer: Nationwide propensity score analysis. Dig Endosc. 2022 Jul;34(5):974-983.

  31. Hosaka H, Kawami N, Manabe N, Kuribayashi S, Sato H, Funaki Y, Ayaki M, Hara K, Ueda C, Matsumura T, Fujiwara Y, Wada M, Kishino M, Yano F, Masaoka T, Ishimura N, Akiyama J, Ochiai Y, Uraoka T, Iwakiri K. Clinical presentation and therapeutic outcome of patients with jackhammer esophagus-a multicenter cohort study in Japan. Esophagus. 2022 Jul;19(3):393-400.

  32. Takahashi K, Ohyama H, Mikata R, Nagashima H, Ohno I, Takiguchi Y, Kato N. Intraperitoneal bleeding from the right gastroepiploic artery by endoscopic ultrasonography: A case report. J Rural Med. 2022 Jul;17(3):184-188.

  33. Takahashi K, Ohyama H, Mikata R, Nagashima H, Ohno I, Takiguchi Y, Kato N. Successful endoscopic retrieval of a migrated pancreatic stent using a basket catheter for peroral cholangioscopy through a biliary plastic stent pusher tube: a case report. J Rural Med. 2022 Jul;17(3):189-192.

  34. Ogasawara S, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Kato N. Changes in therapeutic options for hepatocellular carcinoma in Asia. Liver Int. 2022 Aug;42(9):2055-2066.

  35. Fujiwara K, Yokosuka O, Kato N. Histological re-evaluation of autoimmune hepatitis with acute presentation. Liver Int. 2022 Aug;42(8):1916-1917.

  36. Maruta S, Sugiyama H, Ogasawara S, Sugihara C, Ouchi M, Kan M, Yamada T, Miura Y, Nagashima H, Takahashi K, Kusakabe Y, Ohyama H, Okitsu K, Ohno I, Mikata R, Sakai Y, Tsuyuguchi T, Kato J, Kato N. "Salvage techniques" are the key to overcome difficult biliary cannulation in endoscopic retrograde cholangiopancreatography. Sci Rep. 2022 Aug 10;12(1):13627.

  37. Ozeki Y, Kanogawa N, Ogasawara S, Ogawa K, Ishino T, Nakagawa M, Fujiwara K, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Kojima R, Kanzaki H, Koroki K, Kobayashi K, Nakamura M, Kiyono S, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Nakamoto S, Muroyama R, Tawada A, Chiba T, Arai M, Kato J, Ikeda JI, Takiguchi Y, Kato N. Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis. Int J Clin Oncol. 2022 Sep;27(9):1459-1466.

  38. Fujiwara K, Fukuda Y, Seza K, Saito M, Koizumi S, Yokosuka O, Kato N. Analysis of non-severe acute onset autoimmune hepatitis according to the presence of radiological heterogeneity. Hepatol Res. 2022 Sep;52(9):804-810.

  39. Dao HV, Hoang LB, Luu MT, Nguyen HL, Goldberg R, Allison J, Dao MT, Matsumura T, Dao LV. High prevalence of esophagitis in patients with severe ineffective esophageal motility: need for a new diagnostic cutoff. Ann Gastroenterol. 2022 Sep-Oct;35(5):483-488.

  40. Sakuma T, Nakamura M, Chiba T, Iwanaga T, Kan M, Kojima R, Ao J, Ma Y, Unozawa H, Fujita N, Kanayama K, Kanzaki H, Koroki K, Kobayashi K, Nakagawa R, Kanogawa N, Kiyono S, Kondo T, Saito T, Ogasawara S, Nakamoto S, Muroyama R, Kato J, Kishimoto T, Kato N. A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis. Lab Invest. 2022 Oct;102(10):1150-1157.

  41. Ogasawara S, Kanogawa N, Kato N. How we use hepatic arterial infusion chemotherapy in the new era of systemic therapy? Hepatobiliary Surg Nutr. 2022 Oct;11(5):775-778.

  42. Ma Y, Nakamoto S, Ao J, Qiang N, Kogure T, Ogawa K, Nakagawa M, Fujiwara K, Iwanaga T, Kojima R, Kanzaki H, Koroki K, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Nakagawa R, Ogasawara S, Muroyama R, Chiba T, Kato J, Kato N. Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus. Int J Mol Sci. 2022 Oct 10;23(19):12015.

  43. Takehara T, Izumi N, Mochida S, Genda T, Fujiyama S, Notsumata K, Tamori A, Suzuki F, Suri V, Mercier RC, Matsuda T, Matsuda K, Kato N, Chayama K, Kumada H. Sofosbuvir-velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan. Hepatol Res. 2022 Oct;52(10):833-840.

  44. Nagasaki J, Ishino T, Togashi Y. Mechanisms of resistance to immune checkpoint inhibitors. Cancer Sci. 2022 Oct;113(10):3303-3312.

  45. Sato R, Moriguchi M, Iwai K, Tsuchiya S, Seko Y, Takahashi A, Kobayashi K, Ogasawara S, Watanabe S, Morimoto N, Kato N, Itoh Y, Aramaki T. Real-world outcomes of molecular targeted agents for patients with hepatocellular carcinoma over 80 years old. Hepatol Res. 2022 Oct;52(10):859-871.

  46. Dao HV, Hoang LB, Luu HTM, Nguyen HL, Goldberg RJ, Allison J, Dao ATM, Van Nguyen HT, Matsumura T, Van Dao L. Clinical symptoms, endoscopic findings, and lower esophageal sphincter characteristics in patients with absent contractility. Medicine (Baltimore). 2022 Oct 28;101(43):e31428.

  47. Takahashi K, Ohyama H, Nagashima H, Iino Y, Kusakabe Y, Okitsu K, Ohno I, Takiguchi Y, Kato N. Successful endoscopic treatment of huge infected biloma and hepatic abscess after endoscopic ultrasound-guided hepaticogastrostomy with brain abscess: A case report Clin J Gastroenterol. 2022 Oct;15(5):988-993.

  48. Ohyama H, Hirotsu Y, Amemiya K, Amano H, Hirose S, Hosoda K, Oyama T, Iimuro Y, Kojima Y, Mikata R, Mochizuki H, Kato N, Omata M. Detection of actionable mutations in cytological specimens obtained by endoscopic ultrasound-guided fine needle aspiration with rapid onsite evaluation in pancreatic cancer. Ann Diagn Pathol. 2022 Oct;60:152008.

  49. Ohyama H, Mikata R, Hirotsu Y, Amemiya K, Miura Y, Hirose S, Oyama T, Takano A, Iimuro Y, Kojima Y, Mochizuki H, Ikeda J, Kato N, Omata M. Genomic profiling amplifies the utility of endoscopic ultrasound-guided fine needle biopsy by identifying clinically applicable druggable mutations in pancreatic cancer. Ann Diagn Pathol. 2022 Oct;60:152016.

  50. Miyagishima D, Inoue M, Kinjo K, Fujimoto K, Suzuki H, Sugimura K, Kubota M, Nakagawa A, Kikuchi Y, Shinozaki M, Fujimoto H. A Case of Bowel Obstruction due to Shiitake Mushrooms: Diagnostic Features on Computed Tomography. Intern Med. 2022 Nov 15;61(22):3349-3354.

  51. Kita T, Ashizuka S, Takeda T, Matsumoto T, Ohmiya N, Nakase H, Motoya S, Ohi H, Mitsuyama K, Hisamatsu T, Kanmura S, Kato N, Ishihara S, Nakamura M, Moriyama T, Saruta M, Nozaki R, Yamamoto S, Inatsu H, Watanabe K, Kitamura K. Adrenomedullin for biologic-resistant Crohn’s disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial. J Gastroenterol Hepatol. 2022 Nov;37(11):2051-2059.

  52. Takahashi K, Ohyama H, Ouchi M, Kan M, Nagashima H, Iino Y, Kusakabe Y, Okitsu K, Ohno I, Takiguchi Y, Kato N. Feasibility of endoscopic ultrasound-guided hepaticogastrostomy using a 22-gauge needle. Medicine (Baltimore). 2022 Nov 4;101(44):e31545.

  53. Fujita N, Kanogawa N, Makishima H, Ogasawara S, Maruta S, Iino Y, Shiko Y, Kanzaki H, Koroki K, Kobayashi K, Kiyono S, Nakamura M, Kondo T, Nakamoto S, Chiba T, Wakatsuki M, Itobayashi E, Obu M, Koma Y, Azemoto R, Kawasaki Y, Kato J, Tsuji H, Kato N. Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinoma. Hepatol Res. 2022 Dec;52(12):1060-1071.

  54. Kondo T, Fujiwara K, Nakagawa M, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Ogasawara S, Suzuki E, Ooka Y, Nakamoto S, Chiba T, Arai M, Kato J, Kato N. The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma. Sci Rep. 2022 Dec 1;12(1):20726.

  55. Okimoto K, Matsumura T, Akizue N, Ohta Y, Taida T, Kato J, Kato N. Endoscopic band ligation for the removal of colonic polyp invading the diverticulum. Endoscopy. 2022 Dec;54(12):E713-E714.

  56. Okimoto K, Matsumura T, Akizue N, Ohta Y, Taida T, Saito K, Kato J, Kato N. Utility of a super-soft hood for esophageal endoscopic submucosal dissection below an esophageal stricture. VideoGIE. 2022 Dec 9;8(2):53-55.

  57. Yokoyama Y, Ohta Y, Ogasawara S, Kato J, Arai R, Koseki H, Saito M, Kaneko T, Tokunaga M, Oura H, Oike T, Imai Y, Kanayama K, Akizue N, Kumagai J, Taida T, Okimoto K, Saito K, Ooka Y, Matsumura T, Nakagawa T, Arai M, Katsuno T, Fukuda Y, Kitsukawa Y, Kato N. The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort. Sci Rep. 2022 Dec 6;12(1):21060.

  58. Kawabata H, Tamura T, Tamai S, Takahashi T, Kato J; Study Group. Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study. Int J Hematol. 2022 Dec;116(6):846-855.

2021年

  1. Arai J, Goto K, Otoyama Y, Nakajima Y, Sugiura I, Kajiwara A, Tojo M, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Nozawa H, Nakagawa R, Muroyama R, Kato N, Yoshida H. Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding. Cancer Immunol Immunother. 2021 Jan;70(1):203-213.

  2. Tahata T, Hikita H, Mochida S, Kawada N, Enomoto N, Ido A, YochijiH, Miki D, Hiasa Y, Takikawa Y, Sakamori R, Kurosaki M Yatsuhishi H, Tateishi R, Ueno Y, Itoh Y, Yamashita T, Kanto T, Suda G, Nakamoto Y, Kato N, Asahina Y, Matsuura K, Terai S, Nakao K, Shimizu M, Takami T, Akuta N, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T. Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study. J Gastroenterol. 2021 Jan;56(1):67-77.

  3. Nagai Y, Mimura N, Rizq O, Isshiki Y, Oshima M, Rzik M, Saraya A, Koide S, Nakajima-Takagi Y, Moyota M, Chiba T, Oshima-Hasegawa N, Tsukamoto S, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Iseki T, Lennox W, Sheedy J, Weetall M, Yokote K, Iwama A, Sakaida E. The combination of the tubulin binding small molecule PTC596 and bortezomib suppresses the growth of myeloma cells. Sci Rep. 2021 Jan 22;11(1):2074.

  4. Yokoyama M, Kimura Y M, Ito T, Hayashizaki K, Endo Y, Yagi R, Nakagawa T, Kato N, Matsubara H, Nakayama T. Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease. Front Immunol. 2021 Jan 29;11:594297.

  5. Fujiwara K, Yasui S, Kondo T, Yokosuka O, Kato N. Role of Autoimmunity in Patients Transplanted for Acute Liver Failure of Unknown Origin: A Clinical and Graft Biopsy Analysis. Liver Transpl. 2021 Feb;27(2):309-310.

  6. Kudo M, Tsuchiya K, Kato N, Hagihara A, Numata K, Aikata H, Inaba Y, Kondo S, Motomura K, Furuse J, Ikeda M, Morimoto M, Achira M, Kuroda S, Kimura A. Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study. J Gastroenterol. 2021 Feb;56(2):181-190.

  7. Ryoo BY, Merle P, Kulkarni AS, Cheng AL, Bouattour M, Lim HY, Breder V, Edeline J, Chao Y, Ogasawara S, Yau T, Garrido M, Chan SL, Daniele B, Norquist JM, Chen E, Siegel AB, Zhu AX, Finn RS, Kudo M. Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240. Cancer. 2021 Mar 15;127(6):865-874.

  8. Kanzaki H, Chiba T, Ao J, Koroki K, Kanayama K, Maruta S, Maeda T, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Ogasawara S, Suzuki E, Ooka Y, Muroyama R, Nakamoto S, Yasui S, Tawada A, Arai M, Kanda T, Maruyama H, Mimura N, Kato J, Zen Y, Ohtsuka M, Iwama A, Kato N. The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma. Sci Rep. 2021 Mar 5;11(1):5303.

  9. Hatta W, Tsuji Y, Yoshio T, Kakushima N, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Koike T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribasyashi S, Kiyotoki S, Mabe K, Nakamura T, Nakaya N, Fujishiro M, Masamune A. Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score. Gut. 2021 Mar;70(3):476-484.

  10. Yamauchi Y, Arai M, Akizue N, Ohta Y, Okimoto K, Matsumura T, Meng F, Imai C, Tawada A, Kato J, Kato N, Takiguchi Y. Colonoscopic Evaluation of Diarrhea/Colitis Occurring as an Immune-Related Adverse Event. Jpn J Clin Oncol. 2021 Mar 3;51(3):363-370.

  11. Ishikawa T, Matsumura T, Okimoto K, Nagashima A, Shiratori W, Kaneko T, Oura H, Tokunaga M, Akizue N, Ohta Y, Saito K, Arai M, Kato J, Kato N. Efficacy of Texture and Color Enhancement Imaging in visualizing gastric mucosal atrophy and gastric neoplasms. Sci Rep. 2021 Mar 25;11(1):6910.

  12. Hanai N, Shimizu Y, Kariya S, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Sakurai D, Asakage T, Doi I, Yamada T, Homma A. Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study. Int J Clin Oncol. 2021 Mar;26(3):494-506.

  13. Hisanaga T, Hidaka I, Sakaida I, Nakayama N, Ido A, Kato N, Takikawa Y, Inoue K, Shimizu M, Genda T, Terai S, Tsubouchi H, Takikawa H, Mochida S, and Intractable Hepato‐Biliary Disease Study Group of Japan. Analysis of the safety of pretransplant corticosteroid therapy in patients with acute liver failure and late-onset hepatic failure in Japan. JGH Open. 2021 Mar 5;5(4):428-433.

  14. Iino Y, Maruyama H, Mikata R, Yasui S, Koroki K, Nagashima H, Awatsu M, Shingyoji A, Kusakabe Y, Kobayashi K, Kiyono S, Nakamura M, Ohyama H, Sugiyama H, Sakai Y, Chiba T, Kato J, Tsuyuguchi T, Kato N. Percutaneous Two-Dimensional Shear Wave Elastography for Diagnosis of Pancreatic Tumor. Diagnostics. 2021 Mar 11;11(3):498.

  15. Ao J, Chiba T, Shibata S, Qiang N, Ma Y, Kan M, Iwanaga T, Sakuma T, Kanzaki H, Kanayama K, Kojima R, Kusakabe Y, Nakamura M, Saito T, Nakagawa R, Kondo T, Ogasawara S, Suzuki E, Muroyama R, Kato J, Mimura N, Kanda T, Maruyama H, Kato N. Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2021 Apr 16;549:171-178.

  16. Koroki K, Kanogawa N, Maruta S, Ogasawara S, Iino Y, Obu M, Okubo T, Itokawa N, Maeda T, Inoue M, Haga Y, Seki A, Okabe S, Koma Y, Azemoto R, Atsukawa M, Itobayashi E, Ito K, Sugiura N, Mizumoto H, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Saito T, Kondo T, Suzuki E, Ooka Y, Nakamoto S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Kato J, Kato N. Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Liver Cancer. 2021 Apr 20;10(5):473-484.

  17. Sakai Y, Ohtsuka M, Sugiyama H, Mikata R, Yasui S, Ohno I, Iino Y, Kato J, Tsuyuguchi T, Kato N. Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct. World J Gastroenterol. 2021 Apr 21;27(15):1569-1577.

  18. Otoyama Y, Arai J, Goto K, Nozawa H, Nakagawa R, Muroyama R, Sugiura I, Nakajima Y, Kajiwara A, Tojo M, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Kato N, Yoshida H. Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10. Anticancer Res. 2021 May;41(5):2307-2320.

  19. Saeki I, Yamasaki T, Yamauchi Y, Takami T, Kawaoka T, Uchikawa S, Hiramatsu A, Aikata H, Kawano R, Kobayashi K, Kondo T, Ogasawara S, Chiba T, Chayama K, Kato N, Sakaida I. Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma. Cancers (Basel). 2021 May 7;13(9):2247.

  20. Ogasawara S, Choo SP, Li JT, Yoo C, Wang B, Lee D, Chow PKH. Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia-Pacific Region: A Review and Multidisciplinary Expert Opinion. Cancers (Basel). 2021 May 27;13(11):2626.

  21. Yoshida R, Koroki K, Makishima H, Ogasawara S, Ishino T, Ogawa K, Nakagawa M, Fujiwara K, Unozawa H, Iwanaga T, Fujita N, Sakuma T, Kanzaki H, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Nakamoto S, Tawada A, Chiba T, Arai M, Kaneko T, Wakatsuki M, Kato J, Tsuji H, Kato N. Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma. Case Rep Oncol. 2021 Jul 15;14(2):1103-1110.

  22. Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver Cancer. 2021 Jun;10(3):181-223.

  23. Kudo M, Lim HY, Cheng AL, Chao Y, Yau TCC, Ogasawara S, Kurosaki M, Morimoto N, Ohkawa K, Yamashita T, Lee KH, Chen E, Siegel AB, Ryoo BY. Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial. Liver Cancer. 2021 Jun;10(3):275-284.

  24. Cadoni S, Ishaq S, Hassan C, Přemysl Falt, Fuccio L, Siau K, Leung JW, Anderson J, Binmoeller KF, Radaelli F, Rutter MD, Sugimoto S, Muhammad H, Bhandari P, Draganov PV, Piet de Groen, Wang AY, Yen AW, Hamerski C, Thorlacius H, Neumann H, Ramirez F, Mulder CJ, Albéniz E, Amato A, Arai M, Bak A, Barret M, Bayupurnama P, Cheung R, Ching HL, Cohen H, Dolwani S, Friedland S, Harada H, Hsieh YH, Hayee B, Kuwai T, Lorenzo-Zúñiga V, Liggi M, Mizukami T, Mura D, Nylander D, Olafsson S, Paggi S, Pan Y, Parra-Blanco A, Ransford R, Rodriguez-Sanchez J, Senturk H, Suzuki N, Tseng CW, Uchima H, Uedo N, Leung FW. Water-assisted colonoscopy: an international modified Delphi review on definitions and practice recommendations. Gastrointest Endosc. 2021 Jun;93(6):1411-1420.e18.

  25. Akizue N, Okimoto K, Arai M, Hirotsu Y, Amemiya K, Imai Y, Oike T, Yokoyama Y, Ishikawa K, Ohta Y, Taida T, Saito K, Maruoka D, Matsumura T, Nakagawa T, Nishimura M, Matsushita K, Mochizuki H, Yokosuka O, Omata M, Kato N. Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions. Cancer Med. 2021 Jun;10(11):3545-3555.

  26. Shinzaki S, Matsuoka K, Tanaka H, Takeshima F, Kato S, Torisu T, Ohta Y, Watanabe K, Nakamura S, Yoshimura N, Kobayashi T, Shiotani A, Hirai F, Hiraoka S, Watanabe M, Matsuura M, Nishimoto S, Mizuno S, Iijima H, Takehara T, Naka T, Kanai T, Matsumoto T. Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study. J Gastroenterol. 2021 Jun;56(6):560-569.

  27. Kubota-Aizawa S, Matsubara Y, Kanemoto H, Mimuro H, Uchida K, Chambers J, Tsuboi M, Ohno K, Fukushima K, Kato N, Yotsuyanagi H, Tsujimoto H. Transmission of Helicobacter pylori between a human and two dogs: A case report. Helicobacter. 2021 Jun;26(3):e12798.

  28. Fujita Y, Hoshina T, Matsuzaki J, Yoshioka Y, Kadota T, Hosaka Y, Fujimoto S, Kawamoto H, Watanabe N, Sawaki K, Sakamoto Y, Miyajima M, Lee K, Nakaharai K, Horino T, Nakagawa R, Araya J, Miyato M, Yoshida M, Kuwano K, Ochiya T. Early prediction of COVID-19 severity using extracellular vesicle COPB2. J Extracell Vesicles. 2021 Jun;10(8):e12092.

  29. Hiwasa T, Wang H, Goto KI, Mine S, Machida T, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Sata M, Yamagishi K, Iso H, Sawada N, Tsugane S, Kunimatsu M, Kamitsukasa I, Mori M, Sugimoto K, Uzawa A, Muto M, Kuwabara S, Kobayashi Y, Ohno M, Nishi E, Hattori A, Yamamoto M, Maezawa Y, Kobayashi K, Ishibashi R, Takemoto M, Yokote K, Takizawa H, Kishimoto T, Matsushita K, Kobayashi S, Nomura F, Arasawa T, Kagaya A, Maruyama T, Matsubara H, Tomiita M, Hamanaka S, Imai Y, Nakagawa T, Kato N, Terada J, Matsumura T, Katsumata Y, Naito A, Tanabe N, Sakao S, Tatsumi K, Ito M, Shiratori F, Sumazaki M, Yajima S, Shimada H, Shirouzu M, Yokoyama S, Kudo T, Doi H, Iwase K, Ashino H, Li SY, Kubota M, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Iwadate Y. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke. BMC Med. 2021 Jun 9;19(1):131.

  30. Ueno M, Morizane C, Okusaka T, Mizusawa J, Kataoka T, Ikeda M, Ozaka M, Okano N, Sugimori K, Todaka A, Shimizu S, Mizuno N, Yamamoto T, Sano K, Tobimatsu K, Katanuma A, Miyamoto A, Yamaguchi H, Nishina T, Shirakawa H, Kojima Y, Oono T, Kawamoto Y, Furukawa M, Iwai T, Sudo K, Miyakawa H, Yamashita T, Yasuda I, Takahashi H, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113. Scand J Gastroenterol. 2021 Jun 18;11(1):12885.

  31. Minami T, Tateishi R, Fujiwara N, Nakagomi R, Nakatsuka T, Sato M, Uchino K, Enooku K, Nakagawa H, Fujinaga H, Izumiya M, Hanajiri K, Asaoka Y, Kondo Y, Tanaka Y, Otsuka M, Ohki T, Arai M, Tanaka A, Yasuda K, Miura H, Ogata I, Kamoshida T, Inoue K, Koike Y, Akamatsu M, Mitsui H, Fujie H, Ogura K, Yoshida H, Wada T, Kurai K, Maekawa H, Obi S, Teratani T, Masaki N, Kamiichi H, Ishikawa T, Kato N, Moriya K, Yotsuyanagi H, Koike K for SMART-C investigators. Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals. Liver Cancer. 2021 Jul;10(4):309-319.

  32. Takeuchi T, Miyauchi E, Kanaya T, Kato T, Nakanishi Y, Watanabe T, Kitami T, Taida T, Sasaki T, Negishi H, Shimamoto S, Matsuyama A, Kimura I, Williams IR, Ohara O, Ohno H. Acetate differentially regulates IgA reactivity to commensal bacteria. Nature. 2021 Jul;595(7868):560-564.

  33. Takahashi K, Saito R, Takeuchi Y, Goto C, Awatsu M, Ishikawa K, Ishigami H, Kuga M, Masuya Y. Successful endoscopic closure with endoscopic clips for endoscopic ultrasound related large duodenal perforation. J Rural Med. 2021 Jul;16(3):165-169.

  34. Ishikawa K, Okimoto K, Matsumura T, Hirotsu Y, Amemiya K, Kishimoto T, Imai Y, Oike T, Yokoyama Y, Akizue N, Ohta Y, Taida T, Saito K, Maruoka D, Nakagawa T, Nishimura M, Matsushita K, Mochizuki H, Arai M, Kato J, Yokosuka O, Omata M, Kato N. Comprehensive Analysis of Barrett's Esophagus: Focused on Carcinogenic Potential for Barrett's Cancer in Japanese Patients. Dig Dis Sci. 2021 Aug;66(8):2674-2681.

  35. Suganuma E, Ishikawa T, Kitamura Y, Hayashida T, Matsumura T, Fujie M, Nozaki-Taguchi N, Sato Y, Isono S. Recovery of lower oesophageal barrier function: a pilot study comparing a mixture of atropine and neostigmine and sugammadex: A randomised controlled pilot study. Eur J Anaesth. 2021 Aug 1;38(8):856-864.

  36. Mikata R, Yasui S, Kishimoto T, Kouchi Y, Shingyoji A, Senoo J, Takahashi K, Nagashima H, Kusakabe Y, Ohyama H, Ohno I, Sugiyama H, Chiba T, Kato J, Kato N. Diagnostic value of IMP3 and p53 immunohistochemical staining in EUS-guided fine-needle aspiration for solid pancreatic tumors. Sci Rep. 2021 Aug 26;11(1):17257.

  37. Tokunaga M, Okimoto K, Akizue N, Ishikawa K, Hirotsu Y, Amemiya K, Ota M, Matsusaka K, Nishimura M, Matsushita K, Ishikawa T, Nagashima A, Shiratori W, Kaneko T, Oura H, Kanayama K, Ohta Y, Taida T, Saito K, Matsumura T, Chiba T, Mochizuki H, Arai M, Kato J, Ikeda J, Omata M, Kato N. Genetic Profiles of Barrett’s Esophagus and Esophageal Adenocarcinoma in Japanese patients. Sci Rep. 2021 Sep 3;11(1):17671.

  38. Sugimoto M, Hatta W, Tsuji Y, Yoshio T, Yabuuchi Y, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Murata M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Fujishiro M, Masamune A, Kawai T. Risk Factors for Bleeding After Endoscopic Submucosal Dissection for Gastric Cancer in Elderly Patients Older Than 80 Years in Japan. Clin Transl Gastroenterol. 2021 Sep 24;12(9):e00404.

  39. Kamezaki H, Iwanaga T, Maeda T, Senoo JI, Sakamoto D, Yasui S, Sugiyama H, Tsuyuguchi T, Kato N. Long-term effects of endoscopic papillary large balloon dilation in patients with challenging bile duct calculi: A retrospective observational study. Medicine (Baltimore). 2021 Sep 10;100(36):e27227.

  40. Asano K, Mikata R, Chiba T, Kan M, Maruta S, Yamada T, Miura Y, Shima Y, Sensui M, Nagashima H, Yokoyama M, Ohyama H, Kusakabe Y, Yasui S, Sugiyama H, Ohno I, Kato J, Takano S, Ohtsuka M, Kato N. Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal adenocarcinoma. Pancreatology. 2021 Sep;21(6):1030-1037

  41. Mukai S, Kanzaki H, Ogasawara S, Ishino T, Ogawa K, Nakagawa M, Fujiwara K, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Koroki K, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Muroyama R, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Shiina M, Ota M, Ikeda J, Takiguchi Y, Ohtsuka M, Kato N. Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment. JGH Open. 2021 Oct 1;5(11):1266-1274.

  42. Takahashi S, Matsumura T, Kaneko T, Tokunaga M, Oura H, Ishikawa T, Nagashima A, Shiratori W, Akizue N, Ohta Y, Kikuchi A, Fujie M, Saito K, Okimoto K, Maruoka D, Nakagawa T, Arai M, Kato J, Kato N. Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn. J Neurogastroenterol Motil. 2021 Oct 30;27(4):545-554.

  43. Suzuki T, Seki Y, Matsumura T, Ikari J, Arai M, Hanazawa T, Okamoto Y, Suzuki H, Kurokawa Y, Umezawa A, Kasama K, Hoppo T. "Gas" laryngopharyngeal reflux cause unexplained chronic cough. Auris Nasus Larynx. 2021 Oct;48(5):1026-1030.

  44. Shiroma S, Yoshio T, Hatta W, Tsuji Y, Yabuuchi Y, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Fujishiro M, Masamune A, Ohira H. Timing of bleeding and thromboembolism associated with endoscopic submucosal dissection for gastric cancer in Japan. J Gastroenterol Hepatol. 2021 Oct;36(10):2769-2777.

  45. Kakizaki M, Yamamoto Y, Nakayama S, Kameda K, Nagashima E, Ito M, Suyama T, Matsuzaki Y, Chiba T, Sumiyoshi H, Inagaki Y, Kotani A. Human hepatocyte-derived extracellular vesicles attenuate the carbon tetrachloride-induced acute liver injury in mice. Cell Death Dis. 2021 Oct 27;12(11):1010.

  46. Higuchi R, Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K, Ohyama H, Mochizuki H, Omata M. Sphingomonas and Phenylobacterium as Major Microbiota in Thymic Epithelial Tumors. J Pers Med. 2021 Oct 26;11(11):1092.

  47. Ohyama H, Hirotsu Y, Amemiya K, Oyama T, Iimuro Y, Kojima Y, Mikata R, Mochizuki H, Kato N, Omata M. Detection of actionable mutations in archived cytological bile specimens. J Hepatobiliary Pancreat Sci. 2021 Oct;28(10):837-847.

  48. Sakai Y, Sugiyama H, Kawaguchi Y, Kawashima Y, Hirata N, Nakaji S, Natsui M, Shioji K, Nakahara K, Tsuyuguchi T, Kato N. Uncovered versus covered metallic stents for the management of unresectable malignant distal biliary obstruction: a randomized multicenter trial. Scand J Gastroenterol. 2021 Oct;56(10):1229-1235.

  49. Hashimoto M, Hatta W, Tsuji Y, Yoshio T, Kakushima N, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Koike T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Nakamura T, Nakaya N, Fujishiro M, Masamune A. Rebleeding in patients with delayed bleeding after endoscopic submucosal dissection for early gastric cancer. Dig Endosc. 2021 Nov;33(7):1120-1130.

  50. Minamide T, Sashiyama H, Muramatsu Y, Yada T, Matsumura T, Takeda S, Suzuki T, Kakimoto T, Yano T, Yoshii K, Arai M, Uemura N, Yamaguchi T, Ikematsu H. Second-generation narrow-band imaging to detect colorectal adenomas: A multicenter study including community hospitals. J Gastroenterol Hepatol. 2021 Nov;36(11):3084-3091.

  51. Amano H, Kanda T, Mochizuki H, Kojima Y, Suzuki Y, Hosoda K, Ashizawa H, Miura Y, Tsunoda S, Hirotsu Y, Ohyama H, Kato N, Moriyama M, Obi S, Omata M. The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection. Viruses. 2021 Nov 4;13(11):2216.

  52. Kusakabe Y, Chiba T, Oshima M, Koide S, Rizq O, Aoyama K, Ao J, Kaneko T, Kanzaki H, Kanayama K, Maeda T, Saito T, Nakagawa R, Kobayashi K, Kiyono S, Nakamura M, Ogasawara S, Suzuki E, Nakamoto S, Yasui S, Mikata R, Muroyama R, Kanda T, Maruyama H, Kato J, Mimura N, Ma A, Jin J, Zen Y, Otsuka M, Kaneda A, Iwama A, Kato N. EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma. Sci Rep. 2021 Nov 1;11(1):21396.

  53. Ao J, Chiba T, Kanzaki H, Kanayama K, Shibata S, Kurosugi A, Iwanaga T, Kan M, Sakuma T, Qiang N, Ma Y, Kojima R, Kusakabe Y, Nakamura M, Saito T, Nakagawa R, Kondo T, Ogasawara S, Suzuki E, Nakamoto S, Muroyama R, Tawada A, Kato J, Kanda T, Maruyama H, Kato N. Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma. J Cancer. 2021; 12(9):2694-2701.

  54. Kobayashi K, Ogasawara S, Takahashi A, Seko Y, Unozawa H, Sato R, Watanabe S, Moriguchi M, Morimoto N, Tsuchiya S, Iwai K, Inoue M, Ogawa K, Ishino T, Iwanaga T, Sakuma T, Fujita N, Kanzaki H, Koroki K, Nakamura M, Kanogawa N, Kiyono S, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Nakamoto S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Nagashima K, Kato J, Isoda N, Aramaki T, Itoh Y, Kato N. Evolution of survival impact of molecular target agents in patients with advanced hepatocellular carcinoma. Liver Cancer. 2021 Dec 6;11(1):48-60.

  55. Nakayama N, Uemura H, Uchida Y, Imai Y, Tomiya T, Terai S, Yoshiji H, Genda T, Ido A, Inoue K, Kato N, Sakaida I, Shimizu M, Takikawao Y, Abe M, Abe R, Chayama K, Hasegawa K, Inui A, Kasahara M, Ohira H, Tanaka A, Takikawa H, Mochida S. Nationwide Survey for Patients with Acute-on-Chronic Liver Failure Occurring between 2017 and 2019 and Diagnosed According to Proposed Japanese Criteria. J Gastroenterol. 2021 Dec;56(12):1092-1106.

  56. Kondo T, Macdonald S, Engelmann C, Habtesion A, Macnaughtan J, Mehta G, Mookerjee RP, Davies N, Pavesi M, Moreau R, Angeli P, Arroyo V, Andreola F, Jalan R. The role of RIPK1 mediated cell death in acute on chronic liver failure. Cell Death Dis. 2021 Dec 17;13(1):5.

2020年

  1. Kasai H, Ito S, Tajima H, Takahashi Y, Sakurai Y, Kawata N, Sugiyama H, Asahina M, Sakai I, Tatsumi K. The positive effect of student-oriented clinical clerkship rounds employing role-play and peer review on the clinical performance and professionalism of clerkship students. Med Teach. 2020 Jan;42(1):73-78.

  2. Maruyama H, Kobayashi K, Kiyono S, Chiba T, Kato N, Ohtsuka M, Ito K, Yamaguchi T, Shiina S. Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH). Eur Radiol Exp. 2020 Jan 23;4(1):3.

  3. Sato N, Takano S, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, Suzuki D, Sakai N, Kagawa S, Mishima T, Nakadai E, Mikata R, Kato N, Ohtsuka M. Needle tract seeding recurrence of pancreatic cancer in the gastric wall with paragastric lymph node metastasis after endoscopic ultrasound-guided fine needle aspiration followed by pancreatectomy: a case report and literature review. BMC Gastroenterol. 2020 Jan 15;20(1):13.

  4. Engelmann C, Sheikh M, Sharma S, Kondo T, Loeffler-Wirth H, Zheng YB, Novelli S, Hall A, Kerbert AJC, Macnaughtan J, Mookerjee R, Habtesion A, Davies N, Ali T, Gupta S, Andreola F, Jalan R. Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure. J Hepatol. 2020 Jul;73(1):102-112

  5. Ogasawara S, Ooka Y, Itokawa N, Inoue M, Okabe S, Seki A, Haga Y, Obu M, Atsukawa M, Itobayashi E, Mizumoto H, Sugiura N, Azemoto R, Kanayama K, Kanzaki H, Maruta S, Maeda T, Kusakabe Y, Yokoyama M, Kobayashi K, Kiyono S, Nakamura M, Saito T, Suzuki E, Nakamoto S, Yasui S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Kato N. Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan. Invest New Drugs. 2020 Feb;38(1):172-180.

  6. Ogasawara S, Ooka Y, Kato N. Weight-based dosing of lenvatinib for advanced hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2020 Feb;9(1):253-254.

  7. Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, Jia J, Tian Q, Aggarwal R, Muljono DH, Omata M, Ooka Y, Han KH, Lee HW, Jafri W, Butt AS, Chong CH, Lim SG, Pwu RF, Chen DS. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167-228.

  8. Oura H, Matsumura T, Kawasaki Y, Okimoto K, Ishikawa K, Kaneko T, Tokunaga M, Oike T, Imai Y, Yokoyama Y, Akizue N, Maruoka D, Ohta Y, Saito K, Nakagawa T, Arai M, Kato J, Kato N. Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment. Scand J Gastroenterol. 2020 Feb;55(2):209-215.

  9. Kanayama K, Chiba T, Kobayashi K, Koroki K, Maruta S, Kanzaki H, Kusakabe Y, Saito T, Kiyono A, Nakamura M, Ogasawara S, Suzuki E, Ooka Y, Nakamoto S, Yasui S, Kanda T, Maruyama H, Kato J, Kato N. Long-term administration of Tolvaptan to patients with decompensated cirrhosis. Int J Med Sci. 2020 Mar 15;17(7):874-880.

  10. Kamezaki H, Tsuyuguchi T, Shimura K, Sakamoto D, Senoo J, Mizumoto H, Kubota M, Yoshida Y, Azemoto R, Sugiyama H, Kato N. Safety and Efficacy of Early Tube Removal Following Percutaneous Transhepatic Gallbladder Drainage: An Observational Study. Surg Laparosc Endosc Percutan Tech. 2020 Apr;30(2):164-168.

  11. Ogasawara S, Ooka Y, Koroki K, Maruta S, Kanzaki H, Kanayama K, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Kato N. Switching to systemic therapy after locoregional treatment failure: Definition and best timing. Clin Mol Hepatol. 2020 Apr;26(2):155-162.

  12. Yamato M, Mikata R, Yasui S, Iino Y, Shingyoji A, Kusakabe Y, Ohyama H, Sugiyama H, Sakai Y, Tsuyuguchi T, Yoshitomi H, Ohtsuka M, Kishimoto T, Kato N. Endoscopic Ultrasound Criteria for Arterial Invasion in Pancreatic Cancer of the Body and Tail. Pancreas. 2020 Apr;49(4):561-567.

  13. Nakaji S, Okawa Y, Nakamura K, Itonaga M, Inase M, Sugiyama H, Suzuki R, Yamauchi K, Matsui H, Hirata N, Saito J, Ishii N, Tsuyuguchi T, Kato H, Kitano M, Kato N, Ohira H, Okada H, Torimura T, Maguchi H. Predictive model of bleeding following endoscopic sphincterotomy for the treatment of choledocholithiasis in hemodialysis patients: A retrospective multicenter study. JGH Open. 2020 May 17;4(5):915-922.

  14. Fujisawa T, Shimamura T, Goto K, Nakagawa R, Muroyama R, Ino Y, Horiuchi H, Endo I, Maeda S, Harihara Y, Nakajima A, Matsuhashi N, Kato N, Isayama H, Puri A, Suzuki A, Bellayr I, Leland P, Joshi BH, Puri RK. A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and Its Association With Poor Prognosis of Patients With Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2020 May 20;12(5):1294.

  15. Takahashi K, Nihei T, Aoki Y, Konno N, Nakagawa M, Munakata A, Okawara K, Ohtani H, Kashimura H. Gastric gastrointestinal stromal tumor with predominant cystic formation diagnosed by endoscopic ultrasound-fine needle aspiration. Clin J Gastroenterol. 2020 Jun;13(3):359-364.

  16. Matsumura T, Arai M, Suzuki T, Hoppo T, Seki Y, Kasamatsu S, Ishigami H, Ishikawa K, Okimoto K, Akizue N, Maruoka D, Nakagawa T, Odaka T, Okamoto Y, Kato N. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study. Esophagus. 2020 Jul;17(3):339-347.

  17. Yamamoto Y, Kakizaki M, Shimizu T, Carreras J, Chiba T, Chamoto K, Kagawa T, Aoki T, Nakamura N, Ando K, Kotani A. PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug Entecavir. Int Immunol. 2020 Jul 28;32(8):519-531.

  18. Kudo M, Morimoto M, Moriguchi M, Izumi N, Takayama T, Yoshiji H, Hino K, Oikawa T, Chiba T, Motomura K, Kato J, Yasuchika K, Ido A, Sato T, Nakashima D, Ueshima K, Ikeda M, Okusaka T, Tamura K, Furuse J. A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma. Cancer Sci. 2020 Jul 27;111(10):3759-3769.

  19. Tokunaga M, Matsumura T, Nankinzan R, Suzuki T, Oura H, Kaneko T, Fujie M, Hirai S, Saiki R, Akizue N, Okimoto K, Arai M, Kato J, Kato N. Computer-aided diagnosis system using only white-light endoscopy for the prediction of invasion depth in colorectal cancer. Gastrointest Endosc. 2021 Mar;93(3):647-653.

  20. Takahashi K, Nihei T, Aoki Y, Konno N, Nakagawa M, Munakata A, Okawara K, Ohtani H, Kashimura H. Rapidly progressed large cell neuroendocrine carcinoma of the stomach with an increased serum alpha fetoprotein level: a case report. Clin J Gastroenterol. 2020 Apr;13(2):225-232.

  21. Maruta S, Ogasawara S, Ooka Y, Obu M, Inoue M, Itokawa N, Haga Y, Seki A, Okabe S, Azemoto R, Itobayashi E, Atsukawa M, Sugiura N, Mizumoto H, Koroki K, Kanayama K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Kato N. Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma. Liver Cancer. 2020 Aug;9(4):382-396.

  22. Kan M, Imaoka H, Watanabe K, Sasaki M, Takahashi H, Hashimoto Y, Ohno I, Mitsunaga S, Umemoto K, Kimura G, Suzuki Y, Eguchi H, Otsuru T, Goda K, Ikeda M. Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study. Cancer Chemother Pharmacol. 2020 Aug;86(2):203-210.

  23. Koroki K, Ogasawara S, Ooka Y, Kanzaki H, Kanayama K, Maruta S, Maeda T, Yokoyama M, Wakamatsu T, Inoue M, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Suzuki E, Nakamoto S, Yasui S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Kato J, Kuboki S, Ohtsuka M, Miyazaki M, Yokosuka O, Kato N. Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials. Liver Cancer. 2020 Sep;9(5):596-612.

  24. Viet HD, Matsumura T, Kaneko T, Takahashi S, Tokunaga M, Oura H, Ishikawa K, Akizue N, Kikuchi A, Fujie M, Saito K, Okimoto K, Maruoka D, Nakagawa T, Arai M, Kato J, Kato N. Impact of Ineffective Esophageal Motility on Chemical Clearance in Patients with Gastroesophageal Reflux Symptoms. Dis Esophagus. 2020 Sep 4;33(9):doaa026.

  25. Imai Y, Chiba T, Kondo T, Ao J, Kanayama K, Kanzaki H, Kusakabe Y, Nakagawa R, Nakamura M, Nakamoto H, Muroyama R, Tawada A, Matsumura T, Nakagwa T, Kato J, Kotani A, Matsubara H, Kato N. Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer. Oncol Lett. 2020 Sep;20(3):2161-2168.

  26. Ueshima K, Ogasawara S, Ikeda M, Yasui Y, Terashima T, Yamashita T, Obi S, Sato S, Aikata H, Ohmura T, Hidekatsu K, Ohki T, Nagashima K, Ooka Y, Takita M, Kurosaki M, Chayama K, Kaneko S, Izumi N, Kato N, Kudo M, Omata M. Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Liver Cancer. 2020 Sep;9(5):583-595

  27. Fujiwara K, Nakayama N, Kato N, Yokosuka O, Tsubouchi H, Takikawa H, Mochida S, the Intractable Hepato-Biliary Diseases Study Group of Japan. Infectious complications and timing for liver transsplantation in autoimmune acute liver failure in Japan: A subanalysis based on nationwide surveys between 2010 and 2015. J Gastroenterol. 2020 Sep;55(9):888-898.

  28. Tokunaga M, Matsumura T, Ishikawa K, Kaneko T, Oura H, Ishikawa T, Nagashima A, Shiratori W, Okimoto K, Akizue N, Maruoka D, Ohta Y, Saito K, Nakagawa T, Chiba T, Arai M, Kato J, Kato N. The Efficacy of Linked Color Imaging in the Endoscopic Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Res Pract. 2020 Sep 29;2020:9604345.

  29. Okimoto K, Maruoka D, Matsumura T, Tokunaga M, Kaneko T, Oura H, Akizue N, Ohta Y, Arai M, Kato J, Kato N. Linked color imaging can improve the visibility of superficial non-ampullary duodenal epithelial tumors. Sci Rep. 2020 Nov 26;10(1):20667.

  30. Shingyoji A, Mikata R, Ogasawara S, Kusakabe Y, Yasui S, Sugiyama H, Ohno I, Kato J, Takano S, Yoshitomi H, Ohtsuka M, Kato N. Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer. Jpn J Clin Oncol. 2020 Dec 16;50(12):1403-1411.

  31. Kanogawa N, Ogasawara S, Ooka Y, Inoue M, Wakamatsu T, Yokoyama M, Maruta S, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Koroki K, Kanzaki H, Maeda T, Kobayashi K, Kiyono S, Nakamura M, Kondo T, Saito T, Motoyama T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Kato J, Takemura R, Nozaki-Taguchi N, Shiroh I, Yokosuka O, Kato N. Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma. JGH Open. 2020 Dec 22;5(2):273-279.